Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Cataract extraction with bilateral WIOL-CF polyfocal bioanalogic lens implantation in patients with maculopathy

Poster Details

First Author: M. Alexik SLOVAKIA

Co Author(s):                        

Abstract Details

Purpose:

To assess outcomes of bilateral cataract surgery with WIOL-CF polyfocal bioanalogic lens implantation in patients with bilateral maculopathy in terms of uncorrected distance, intermediate and near visual acuity.

Setting:

Prospective nonrandomized case series, each patient operated by single surgeon (author) at Očné oddelenie, Fakultná nemocnica s poliklinikou Žilina, Slovakia

Methods:

10 patients (20 eyes) with cataract and mild maculopathy were assigned to have bilateral implantation of a WIOL-CF polyfocal bioanalogic lens (MEDICEM Technology s.r.o., Czech Republic) in the capsular bag. Maculopathies were stable at least one year with best corrected visual acuity was 20/63 or better and included lamellar macular hole, diabetic macular edema, branch retinal vein occlusion and dry age related macular degeneration. Dominant eye was targeted to emmetropia whereas non-dominant eye to -0,5 diopter refraction. Uncorrected distance, intermediate and near visual acuity were assessed at follow-up visits (2 weeks, 2 months, 6 months postoperatively).

Results:

Binocular 6 months postoperative outcomes were as follows: mean uncorrected distance visual acuity was 0,06±0,02 logMAR, mean uncorrected intermediate visual acuity was 0,32±0,04 logMAR and mean uncorrected near visual acuity was 0,22±0,13 logMAR. Macular pathologies remained morphologically stable.

Conclusions:

Cataract extraction with binocular WIOL-CF implantation provides remarkable results and spectacle free vision in all distances even in patients with mild maculopathy.

Financial Disclosure:

One or more of the authors travel has been funded, fully or partially, by a competing company

Back to Poster listing